UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Polymeric Micelles in Cancer Immunotherapy

Molecules (Basel, Switzerland), 2021-02, Vol.26 (5), p.1220

2021

Volltextzugriff (PDF)

Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment

Oncoimmunology, 2020-01, Vol.9 (1), p.1708064-1708064

2020

Volltextzugriff (PDF)

Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination

Molecular therapy. Nucleic acids, 2021-12, Vol.26, p.594-602

2021

Volltextzugriff (PDF)

IL1R2 increases regulatory T cell population in the tumor microenvironment by enhancing MHC-II expression on cancer-associated fibroblasts

Journal for immunotherapy of cancer, 2022-09, Vol.10 (9), p.e004585

2022

Volltextzugriff (PDF)

710 Development of IL-33 as a novel immunotherapy of cancer

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A752-A752

2020

Volltextzugriff (PDF)

Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8 + T Cells

Frontiers in cell and developmental biology, 2021-01, Vol.9, p.640224-640224

2021

Volltextzugriff (PDF)

The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy

Frontiers in cell and developmental biology, 2021-11, Vol.9, p.779865-779865

2021

Volltextzugriff (PDF)

Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma

Hepatology communications, 2022-05, Vol.6 (5), p.1123-1139

2022

Volltextzugriff (PDF)

The IL-1 family in tumorigenesis and antitumor immunity

Seminars in cancer biology, 2022-11, Vol.86, p.280-295

2022

Volltextzugriff (PDF)

Activation of Liver X Receptor α Sensitizes Mice to T‐Cell Mediated Hepatitis

Hepatology communications, 2020-11, Vol.4 (11), p.1664-1679

2020

Volltextzugriff (PDF)

Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy

Nature nanotechnology, 2023-02, Vol.18 (2), p.193-204

2023

Volltextzugriff (PDF)

Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia

Journal of leukocyte biology, 2021-02, Vol.109 (2), p.425-436

2021

Volltextzugriff (PDF)

A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death

Biomaterials, 2021-03, Vol.270, p.120708-120708, Article 120708

2021

Volltextzugriff (PDF)

Targeting Xkr8 via Nanoparticles-Mediated In Situ Codelivery of SiRNA and Chemotherapy Drugs for Cancer Immunochemotherapy

Nature nanotechnology, 2022-11, Vol.18 (2), p.193-204

2022

Volltextzugriff (PDF)

Prognostic significance of resident CD103+CD8+T cells in human colorectal cancer tissues

Acta histochemica, 2019-07, Vol.121 (5), p.657-663

2019

Volltextzugriff (PDF)

Tumor-Derived IL33 Promotes Tissue-Resident CD8 + T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy

Cancer immunology research, 2020-11, Vol.8 (11), p.1381-1392

2020

Volltextzugriff (PDF)

Amphiregulin couples IL1RL1 + regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity

Science advances, 2023-08, Vol.9 (34), p.eadd7399

2023

Volltextzugriff (PDF)

Abstract 1326: Loss of p53 sensitizes tumor cells to immune checkpoint blockade therapy via upregulation of IL-33

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1326-1326

2022

Volltextzugriff (PDF)

Abstract B06: Immune inhibitory receptors restrain hyperactivated effector T cells in the tumor microenvironment

Cancer immunology research, 2020-04, Vol.8 (4_Supplement), p.B06-B06

2020

Volltextzugriff (PDF)

Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment

Cancer research communications, 2023-08, Vol.3 (8), p.1460-1472

2023

Volltextzugriff (PDF)

Targeting metabotropic glutamate receptor 4 for cancer immunotherapy

Science advances, 2021-12, Vol.7 (50), p.eabj4226-eabj4226

2021

Volltextzugriff (PDF)

Tumor-derived interleukin-33 promotes tissue-resident CD8+ T cells and is required for checkpoint blockade tumor immunotherapy

Cancer immunology research, 2020-09, Vol.8 (11), p.1381-1392

2020

Volltextzugriff (PDF)

Investigation of damping coefficients for elastic collision particles utilizing the acoustic frequency sampling method

Scientific reports, 2024-04, Vol.14 (1), p.9060-9060, Article 9060

2024

Volltextzugriff (PDF)

The relationship between clustering and networked Turing patterns

Chaos (Woodbury, N.Y.), 2024-07, Vol.34 (7)

2024

Volltextzugriff (PDF)

Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice

International journal of molecular sciences, 2023-03, Vol.24 (7), p.6554

2023

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Polymeric Micelles in Cancer Immunotherapy

Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment

Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination

IL1R2 increases regulatory T cell population in the tumor microenvironment by enhancing MHC-II expression on cancer-associated fibroblasts

710 Development of IL-33 as a novel immunotherapy of cancer

Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8 + T Cells

The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy

Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma

The IL-1 family in tumorigenesis and antitumor immunity

Activation of Liver X Receptor α Sensitizes Mice to T‐Cell Mediated Hepatitis

Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy

Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia

A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death

Targeting Xkr8 via Nanoparticles-Mediated In Situ Codelivery of SiRNA and Chemotherapy Drugs for Cancer Immunochemotherapy

Prognostic significance of resident CD103+CD8+T cells in human colorectal cancer tissues

Tumor-Derived IL33 Promotes Tissue-Resident CD8 + T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy

Amphiregulin couples IL1RL1 + regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity

Abstract 1326: Loss of p53 sensitizes tumor cells to immune checkpoint blockade therapy via upregulation of IL-33

Abstract B06: Immune inhibitory receptors restrain hyperactivated effector T cells in the tumor microenvironment

Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment

Targeting metabotropic glutamate receptor 4 for cancer immunotherapy

Tumor-derived interleukin-33 promotes tissue-resident CD8+ T cells and is required for checkpoint blockade tumor immunotherapy

Investigation of damping coefficients for elastic collision particles utilizing the acoustic frequency sampling method

The relationship between clustering and networked Turing patterns

Cycloastragenol: A Novel Senolytic Agent That Induces Senescent Cell Apoptosis and Restores Physical Function in TBI-Aged Mice

Suchergebnisse filtern